K63.81
Dieulafoy lesion of intestine
Clinical Classification Guidelines
Excludes Type 2
- Dieulafoy lesion of stomach and duodenum (K31.82)
Medical Intelligence & Overview
A Dieulafoy lesion of the intestine is a rare but significant condition characterized by an abnormal blood vessel in the gastrointestinal tract. This abnormality can cause severe bleeding, leading to symptoms like vomiting blood or passing blood through stools. Although it is a rare cause of gastrointestinal bleeding, recognizing and understanding this lesion is crucial for prompt diagnosis and management. The condition is classified under ICD-10 code K63.81 and often requires medical attention to prevent serious complications.
Causes & Symptoms
Clinical Causes: Congenital abnormality of blood vessels in the gastrointestinal mucosa Degeneration of blood vessels with age Development of abnormal submucosal arteries that may erode through the mucosal surface Underlying gastrointestinal disorders or inflammation that weaken blood vessel walls
Key Symptoms: Sudden onset of painless gastrointestinal bleeding Vomiting blood (hematemesis) Passing blood in the stool (melena or hematochezia) Signs of anemia such as fatigue or weakness in chronic cases Potential for repeated bleeding episodes
Diagnostic & Treatment
Diagnosis Path: Diagnosing a Dieulafoy lesion involves several steps, often starting with the patient’s medical history and physical examination. Key diagnostic methods include: - **Endoscopy:** The primary and most effective tool for visualizing the lesion; it can reveal a small mucosal defect with a visible, protruding arteriole. - **Angiography:** May be used when bleeding is active and not visible on endoscopy; it helps identify bleeding vessels. - **Other imaging tests:** Such as CT scans, though less specific, may assist in complex cases. Early detection via endoscopy is essential for accurate diagnosis and guiding treatment options.
Treatment Protocols: Management of a Dieulafoy lesion typically involves controlling bleeding and preventing recurrence. Common treatment approaches include: - **Endoscopic therapy:** The first-line treatment, which may involve: - Mechanical methods such as clips or band ligation - Thermal coagulation techniques - Injection of sclerosing agents to promote clotting - **Vascular interventions:** Such as angiographic embolization if endoscopy is unsuccessful. - **Surgical intervention:** Reserved for cases where bleeding cannot be controlled via endoscopy or if rebleeding occurs; procedures might include segmental resection of the affected intestine. Supportive care is also vital, including blood transfusions if necessary, and addressing underlying health conditions. The goal of treatment is to halt bleeding, restore normal blood levels, and prevent future episodes.
Clinical Advice & FAQs
Billing Guidance
Is K63.81 a billable ICD-10 code?
Yes, K63.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K63.81?
Clinical documentation must specify the nature of Dieulafoy lesion of intestine and any associated comorbidities for accurate reporting.
Cite this Clinical Reference